Myelodysplasia/acute myeloid leukemia (MDS/AML) is characterized by a t(3;5)(q25.1;q34) chromosomal translocation that forms a fusion gene between nucleophosmin (NPM) and MDS/myeloid leukemia factor 1 (MLF1). We identified a novel protein, MLF1-interacting protein (MLF1IP), that specifically associates with MLF1 by yeast two-hybrid analysis and in pulldown assays, and colocalizes with it in both the nuclei and cytoplasm of cells. The MLF1IP gene locus is at chromosome 4q35.1 and is composed of 14 exons spanning 75.8 kb of genomic DNA. The MLF1IP cDNA encodes a 46-kDa protein that contains two bipartite and two classical nuclear localization signals, two nuclear receptor-binding motifs (LXXLL), two leucine zippers, two PEST residues and several potential phosphorylation sites. MLF1IP transcripts are expressed in a variety of tissues (e.g. fetal liver, bone marrow, thymus and testis). MLF1IP appears to be a lineage-specific gene whose expression is confined exclusively to the CFU-E erythroid precursor cells, but not in mature erythrocytes. These observations, together with previous data demonstrating a role for MLF1 in suppressing red cell maturation, suggest a possible role for MLF1IP and MLF1 deregulation in the genesis of erythroleukemias.
Introduction
The t(3;5)(q25.1;q34) chromosomal translocation in myelodysplasia (MDS) and acute myeloid leukemia (AML) produces a fusion gene between nucleophosmin (NPM) and myeloid leukemia factor 1 (MLF1) (Yoneda-Kato et al., 1996) . NPM is a major nucleolar phosphoprotein that is more abundant in tumors and proliferating cells than in normal resting cells (Chan et al., 1989) . It shuttles between the nucleus and cytoplasm, and functions in ribosomal protein assembly and transport (Olson et al., 1986) . NPM was recently shown to interact with the p53 tumor suppressor and regulate its transcriptional activation (Colombo et al., 2002) . It is also a substrate of CDK2/cyclin E and is involved in the initiation of centrosome duplication (Tokuyama et al., 2001 ).
An apoptotic function for NPM-MLF1 was reported to be dependent upon the presence of the NPM dimerization domain (Yoneda-Kato et al., 1999) . Therefore, the relocalization of MLF1 from the cytosol to the nuclear compartment when fused to NPM may provide it with novel interaction partners that could dysregulate both growth control and cell death signaling pathways and lead to the development of myeloid neoplasia.
The MLF1 amino-acid sequence is highly conserved between mouse and humans, and was shown to include an N-terminal 14-3-3-binding motif in both species (Hitzler et al., 1999) . Phosphorylation of serine residues within this motif induces association with 14-3-3 family members (Yaffe et al., 1997) , which in turn interact with a number of cellular proteins to modulate signal transduction (Peng et al., 1997; Fanger et al., 1998) . MLF1 was recently reported to associate with the 14-3-3z isoform and a novel protein called MADM in a yeast two-hybrid screen (Lim et al., 2002) .
A role for MLF1 in the myeloid lineage was demonstrated when MLF1 was isolated as a gene expressed when the J2E proerythroblastic cells underwent a spontaneous phenotypic change to display morphological and biochemical features of monocytoid cells (Williams et al., 1999) . Moreover, enforced expression of MLF1 in the parental J2E cells induced a monoblastoid phenotype, thus recapitulating the spontaneous erythroid to myeloid lineage switch (Williams et al., 1999) , indicating MLF1 involvement in erythroid/ myeloid lineage determination and in normal hematopoiesis.
To further elucidate the biological functions of MLF1, we performed a yeast two-hybrid analysis to identify additional molecules that specifically associate with MLF1. A novel protein that interacts with MLF1 was isolated and their interaction was confirmed by glutathione-S-transferase (GST)-pulldown assays and colocalization experiments. We have named this molecule MLF1IP (MLF1-interacting protein, official HUGO Nomenclature Committee designation), and identified its MLF1-interaction domain. The expression profile of MLF1IP in erythroblasts is consistent with a possible function for MLF1IP and MLF1 in the development of erythroleukemias.
Results

Identification of MLF1IP
Yeast two-hybrid screening was performed to identify proteins that interact with MLF1. In all, 45 clones were confirmed to encode fragments of a novel protein that specifically interacted with MLF1, which we named MLF1IP. MLF1IP clones ranged in size from 240 to 2375 bp, but none included an ATG initiator codon. The longest contained a stop codon followed by 1229-bp 3 0 -untranslated sequences. Database searches revealed MLF1IP to be identical to a partial anonymous cDNA clone deposited with Accession No. AK027121.1. Further analysis by 5 0 -RACE revealed an additional 540 bp of 5 0 -MLF1IP sequences. The completed nucleotide sequence showed MLF1IP cDNA to contain an open reading frame of 1257 nucleotides, with 487-bp 5 0 -UTR and 1229-bp 3 0 -UTR ( Figure 1a ). This nucleotide sequence of full-length human MLF1IP has been deposited in GenBank (Accession No. AF51670). Two in-frame stop codons were identified in the 5'-UTR at nucleotides 14 and 281, upstream of the probable initiating ATG (Kozak, 2000) . Translation from this initiator codon predicts a polypeptide of 418 amino acids, with a molecular mass of 46 kDa. In vitro transcription/translation (IVT) of MLF1IP cDNA The MLF1IP gene is localized to chromosome 4q35.1 and organized into 14 exons, spanning 75.8 kb of genomic sequence (Figure 1b) . Two bipartite and two classical nuclear localization signals (NLSs) are present in MLF1IP (Figures 1a, b) , suggesting it to be a nuclear protein. MLF1IP contains several potential phosphorylation sites that include three putative cyclic AMP sites, 10 possible protein kinase C sites and seven potential casein kinase II (CKII) sites. These putative phosphorylation sites, in particular, the CKII site located within the spacer of the second putative bipartite NLS, may play a role in regulating MLF1IP nuclear transport (Rihs et al., 1991) . Two regions rich in glutamic acid, serine, proline and threonine residues (PEST sequences) were identified in MLF1IP (Figures 1a, b) , implying that the protein may be rapidly degraded in vivo (Rechsteiner and Rogers, 1996) . Two LXXLL consensus motifs are localized in the C-terminus of MLF1IP, indicating that it may function as a nuclear receptor-binding protein (Figure 1a ), as reported for other molecules (Eckner et al., 1994; Heery et al., 1997) . In addition, the coiledcoil structures of two potential leucine zippers (LZ) were identified at the extreme C-terminus of MLF1IP (Figures 1a, b ) through which it may dimerize with other proteins (Bornberg-Bauer et al., 1998) . The shortest MLF1IP cDNA clone that interacted with MLF1 in our yeast two-hybrid screen was 240 bp in length and mapped to exon 7, which encodes amino acids 128-206. Sequence comparisons of MLF1IP revealed 57% overall amino acid identity to a previously uncharacterized mouse protein (XP_134129) (Figure 1c) , and 36% identity with a predicted protein from the rat (XP_224859.1) (not shown). Interestingly, the C-terminal 120 amino acid portion of MLF1IP is highly conserved in all three species, where they share greater than 70% identity. This region contains a bipartite NLS, two LZ, the nuclear receptor-binding motifs and the SMC-homology region, all of which are retained in the mouse and rat proteins. The mouse MLF1IP homolog is encoded for by 13 exons, and is localized to chromosome 8B1.1, which is syntenic to human chromosome 4q35.1, as shown by the human-mouse conserved synteny maps at the NCBI database.
Northern blot analysis of MLF1IP expression
Northern blot analysis revealed that MLF1IP expression was highest in human testis (not shown), fetal liver, thymus and bone marrow, but lower in lymph nodes, placenta, colon and spleen ( Figure 2a ). In addition to the predominant 2.4-kb MLF1IP transcript, these tissues expressed two larger mRNA species, approximately 4.4 and 7.0 kb in size. In the mouse, MLF1IP expression was highest in the testis, spleen and heart. These tissues expressed two mRNA species, approximately 2.4 and 4.4 kb in size. Mouse kidney, liver, lung and brain exhibited only the 4.4-kb transcript ( Figure 2b ). To explain the presence of the larger transcripts, the UCSC Genome Browser was queried using BLAT with the 2.4-kb mouse MLF1IP coding sequence (XM_134129.2). This analysis showed the potential for a 4.8-kb transcript in the mouse. Similar analysis using human MLF1IP revealed a putative transcript of about 3.6 kb in size (data not shown).
Northern blot analysis using poly(A) þ RNA from mouse embryos at different stages of development (embryonic days 7-17) revealed a single predominant MLF1IP transcript of about 2.4 kb. MLF1IP expression was high at all of the embryonic stages studied and highest at E11 (Figure 2b ).
MlF1IP expression in hematopoietic precursor cells
cDNA was globally amplified from mouse bone marrow precursor cells sampled homogeneously from defined stages of the differentiation hierarchy (Billia et al., 2001) . cDNA dot blots ( Figure 2c ) included samples from multipotent in vivo reconstituting stem cells (sample 35), multipotent in vitro colony-forming cells with erythroid and other potentials (samples 1-4), CFU-GM (sample 5), primitive committed erythroid precursors (BFU-E, sample 6) and more advanced erythropoietin-responsive precursors (CFU-E, sample 7) close to the proerythroblast stage (Iscove, 1977) . Also represented were committed precursors of macrophages and neutrophils (samples 8 and 9), terminally maturing cells in myeloid and lymphoid lineages (samples 10-17) and a variety of whole-organ samples. The blots were hybridized with a 329-bp probe designed to target the 3 0 -untranslated sequences of the MLF1IP gene and with a probe for ribosomal L32 as a loading control. Hybridization of the MLF1IP probe was strong to CFU-E and testis cDNA, weak to CFU-GM and mature B-cell samples and negligible in the others.
RNA-PCR analysis of MLF1IP transcripts
Since our Northern blot analysis revealed differently sized transcripts for MLF1IP (Figures 2a, b) , RNA-PCR analysis was performed for determination of isoforms of the gene in mouse tissues. Primers designed to obtain the entire coding region of MLF1IP amplified full-length MLF1IP from most tissues (Figure 3) . However, only an 800-bp product was detected from the lung, whereas in addition to the full-length MLF1IP, brain and spleen expressed an 800-or 570-bp product, respectively (Figure 3 ). Sequencing revealed that different MLF1IP isoforms are present in these tissues, and exons 2, 3, 5 and 6 are absent from the brain, exons 4-6 from the lung and exons 2-6 and 8 from the spleen isoform. The brain isoform could encode for a 30 kDa protein, as detected by IVT, while no protein was obtained from the lung and spleen isoforms (data not shown). These data suggest that alternative forms of MLF1IP may serve tissue-specific functions. The nucleotide sequence of mouse MLF1IP brain isoform has been deposited in GenBank (Accession No. AY366362).
Detection of MLF1IP and MLF1 proteins in mouse organs
Immunoblotting mouse tissue lysates with anti-MLF1 revealed a single band of about 32 kDa (Figure 4a ). MLF1 expression was high in murine erythroleukemia (Mel) cells, but extremely low in Cos7 cells (Figure 4b ), as reported (Yoneda-Kato et al., 1996) . Western blotting with anti-MLF1IP detected a 46 kDa band in all tissues (Figure 4a ). Proteins with slower mobilities were also detected and may correspond to phosphorylated forms of MLF1IP, whereas the faster migrating bands may represent proteolytic degradation products. Western blotting of several cell lines revealed high MLF1IP expression in Mel cells, with lower levels in K562, Hel and HeLa, and undetectable expression in Cos7 cells (Figure 4b ). These data demonstrate that MLF1IP and MLF1 proteins share a similar tissue and cellular expression pattern.
Developmental expression pattern of MLF1IP
In situ hybridization studies were carried out on mouse embryos of embryonic ages 11.5, 13.5, 15.5, 17.5 and 19.5 days, newborn and adult mice. MLF1IP expression was detected in the liver at embryonic day 13.5 ( Figure 4c ). MLF1IP was strongly expressed in the cephalic mesenchyme and roof of the hindbrain, the lining of the pericardial cavity and the atrial chamber of the heart, and the lumen of the stomach in 11.5-day embryos (Figure 4c ). MLF1IP mRNA was also highly (Figure 4c) . Thus, MLF1IP expression occurred in a specific pattern during development and adult life.
To correlate the expression pattern of MLF1IP transcripts with tissue distribution of the protein, immunohistochemistry was performed on sections of adult mouse testis. This revealed an elevated MLF1IP expression in the spermatogenic cell layers (Figure 4d) , suggesting that the protein may play a role in spermatogenesis.
MLF1IP protein binds MLF1 in vitro
A 46-kDa full-length 35 S-labeled MLF1IP protein was produced by in vitro transcription/translation, IVT-MLF1IP, and used to investigate its interaction with GST-MLF1. Figure 5a shows that GST-full-length MLF1 is capable of binding to IVT-MLF1IP, whereas the GST-only control did not bind the protein. GST-NPM-MLF1 was also able to bind IVT-MLF1IP.
To investigate the interaction between MLF1 and MLF1IP by coimmunoprecipitation, Cos7 cells were transfected with full-length MLF1, NPM-MLF1 or MLF1IP. Western blot analysis revealed high levels of the proteins in cells transfected with each construct alone (data not shown). When MLF1 or NPM-MLF1 was cotransfected with MLF1IP, we were unable to detect MLF1IP expression, whereas MLF1 and NPM-MLF1 levels were significantly lower (data not shown). To determine whether this was due to a technical problem or a bona fide biological consequence of cotransfection with MLF1 or NPM-MLF1, we cotransfected Cos7 cells with MLF1IP and MLF2, since MLF2 has 40% identity to MLF1 (Kuefer et al., 1996) , and because MLF1IP does not associate with MLF2 (data not shown). Cotransfection of MLF2 with MLF1IP did not alter the expression level of either protein (data not shown). Moreover, Tunel assays were performed on cells cotransfected with MLF1 and MLF1IP; however, no significant increase in apoptotic cell number was observed in these transfectants (data not shown). Although it is unclear why coexpression of MLF1 or NPM-MLF1 with MLF1IP is not well tolerated by cells, our observations raise the possibility that these proteins may regulate the expression and function of one another. We performed in vitro pulldown assays to confirm the interaction between MLF1 and MLF1IP. GST-MLF1 or GST-only control proteins immobilized on glutathione-sepharose beads were incubated with lysates from Cos7 cells overexpressing Flag-MLF1IP. As shown in Figure 5b , GST-MLF1 was capable of binding to Flag-MLF1IP, whereas the GST-only control protein did not bind MLF1IP. These data confirm the association between MLF1IP and MLF1 identified by yeast two-hybrid analysis.
Subcellular localization of MLF1IP
Immunofluorescence (IF) studies revealed that MLF1IP was present mainly in the nuclei of transfected Cos7 cells, whereas MLF1 was mostly confined to the cytoplasm. When Cos7 cells were cotransfected with both MLF1 and MLF1IP, even though we were unable to detect MLF1IP by Western blotting, IF analysis showed that about 1% of the cells were double-positive. Moreover, these cells had an abnormal phenotype and appeared very large and multinucleated (Figure 5c ), suggesting that they may be unable to undergo normal cell division.
Analysis of K562 human erythroleukemia cells that express MLF1IP and MLF1 (Figure 4b) showed both proteins to be colocalized in the nuclear and cytoplasmic compartments (Figure 5d ). This observation indicates that MLF1IP and MLF1 can be coexpressed in some cells and share overlapping subcellular localizations.
Discussion
MLF1 is a protein identified in MDS/AML as a t(3;5)(q25.1;q34) chromosomal translocation partner with NPM in the fusion gene NPM-MLF1 (YonedaKato et al., 1996) . The normal MLF1 protein lacks any known functional motifs other than a 14-3-3-binding site, and is expressed in some leukemia cell lines, but not in the blasts of t(3;5)-positive AML patients. MLF1 associates with 14-3-3z and the novel protein MADM (Lim et al., 2002) . The exact role of MLF1 in hematopoiesis is not known. Studies suggesting its involvement in lineage determination of hematopoietic cells and that its dysregulation is critical in leukemogenesis have been reported (Williams et al., 1999; Matsumoto et al., 2000) . In this paper, the association of the novel protein MLF1IP with MLF1 was identified by yeast two-hybrid analysis, and confirmed by in vitro pulldown assays. Moreover, we have demonstrated that these proteins have similar tissue distributions, and can share subcellular compartments.
The MLF1IP gene is localized on human chromosome 4q35.1 and is organized into 14 exons. We have identified mouse and rat MLF1IP homologs, and mapped its MLF1-interaction domain. MLF1IP contains several NLS motifs and localizes in the nuclei and . Cells were immunostained with anti-Flag M2, followed by rat anti-mouse-FITC (a, g), anti-MLF1 followed by goat anti-rabbit-FITC (d) or goat-anti-rabbit-Texas red (h). Nuclei were stained with propidium iodide (b, c, e, f) or Toto-3 (i, j). (D) MLF1IP and MLF1 colocalize in K562 cells. Cells were immunostained with anti-MLF1 followed by goat anti-rabbit-FITC (a), anti-MLF1IP-biotinylated followed by avidin-Texas red (b) or the two together (c). Panels d-f control staining with biotinylated normal rabbit IgG cytoplasm of cells. A nuclear function for MLF1IP is supported by the presence of two nuclear receptorbinding motifs. The detection of two LZ at the extreme C-terminus of MLF1IP suggests that it may dimerize with other proteins through these motifs.
MLF1IP shows 25% identity to the SMC family of proteins (Schmiesing et al., 1998; Gregson et al., 2001) , and some homology to myosin (Cope et al., 1996) , moesin, which is involved in actin cytoskeletal organization (Speck et al., 2003) , and to a lesser extent to vacuolar ATPase subunit a, which targets this proton pump to various cellular locations (Kawasaki-Nishi et al., 2001) . SMC and myosin families are ATP-driven molecular motors involved in a number of cellular events such as movement, translocation, cell division and maintenance of cellular structures. Human SMC1 is an integral component of the functional kinetochore structure during mitosis (Gregson et al., 2002) . Intriguingly, we have preliminary data from yeast two-hybrid screens demonstrating MLF1IP association with proteins involved in cell division. These include a kinetochore protein that interacts with SMC1/SMC2, as well as a motor protein (unpublished data). This suggests that MLF1IP may be a part of a multiprotein complex that includes MLF1, 14-3-3z, MADM, its associated serine kinase, kinetochore and motor proteins, and could play an essential function in cell division.
Northern blot analyses demonstrated high-level MLF1IP expression in hematopoietic organs and testis, the presence of differently sized transcripts in some of the organs studied, and tissue-specific transcripts in others, which our RNA-PCR analysis showed to be alternatively spliced forms of MLF1IP. These isoforms lacked the MLF1-interaction domain, and hence could serve MLF1-independent functions.
Analysis of hematopoietic cells revealed that MLF1IP may be a lineage-specific gene with expression confined mainly to the erythroid lineage, as it was expressed exclusively in CFU-E erythroid precursor cells, but not in mature erythrocytes. MLF1 overexpression has been shown to inhibit erythropoietin-induced differentiation of J2E erythroleukemia cells and BFU-E, and chemically induced maturation of Mel cells (Williams et al., 1999) . These data suggest that overexpression of MLF1 suppresses red cell maturation and may account for the large number of erythroleukemias (FAB-M6) associated with the t(3;5)/NPM-MLF1 translocation (Raimondi et al., 1989) . The expression profile of MLF1IP in erythroblasts and its total absence in differentiated erythrocytes supports a likely role for deregulation of both MLF1IP and MLF1 in erythroleukemias.
Materials and methods
Yeast two-hybrid analysis
The yeast strain AH109 was used in yeast two-hybrid screening according to the manufacturer's protocol (Clontech, Palo Alto, CA, USA). Full-length human MLF1 was subcloned into the EcoRI/SalI sites of the PGBKT7 vector to generate a Gal4 DNA-binding domain fusion. AH109 was transformed with PGBKT7-MLF1 and used to screen a Matchmaker pACT2-cDNA library prepared from the human erythroleukemia cell line K562 (Clontech). To obtain the full-length sequence for MLF1IP, we performed 5 0 -RACE using human fetal liver poly(A) þ RNA and the Smart Race kit according to the manufacturer's instructions (Clontech).
Northern blot analysis
Northern blots prepared from poly(A) þ RNA of human and mouse tissues (Clontech) were hybridized with [a-32 P]dCTP labeled probes encoding full-length hu-MLF1IP, or a 300 bp mu-MLF1IP fragment and exposed to film. The probes were removed following the manufacturer's recommendations, and the blots were rehybridized with a 600 bp GAPDH cDNA probe.
Western blots and RT-PCR
Mouse tissues were collected in liquid nitrogen, pulverized and subjected to Western blot analysis. The remainder of the samples were resuspended in RNA STAT-60, and RNA extracted according to the manufacturer's instructions (Tel Test, Inc., Friendswood, TX, USA). RNA was converted to cDNA with the First Strand Synthesis kit (Invitrogen), and amplified using primers specific for the coding region of mouse MLF1IP.
Dot blot analysis
cDNA was generated from single hematopoietic precursor and terminally differentiating cells, or mouse tissues and dotblotted onto Hybond nylon membrane (Amersham), as described (Billia et al., 2001) . A 329-bp probe from the 3 0 -UTR of mu-MLF1IP was prepared as a PCR fragment from mouse testis cDNA (Clontech), labeled by random-priming with [a-32 P]dCTP, and used for hybridization.
In situ hybridization and immunohistochemistry
In situ hybridizations were performed as described (Wilkinson, 1992) . A 300-bp mouse MLF1IP cDNA was cloned into the Topo TA PCRII vector (Invitrogen). The vector was linearized with either XhoI (SP6; antisense) or BamHI (T7; sense) before riboprobe synthesis.
Immunohistochemistry was carried out as detailed previously (Ausubel, 1992) . Briefly, testes of an adult mouse were cut into 20 mm sections, and incubated overnight with anti-MLF1IP followed by goat-anti-rabbit IgG-FITC for 3 h. The slides were mounted and visualized by confocal microscopy.
GST-pulldown assays and immunoblotting
GST fusion proteins consisting of full-length MLF1 and NPM-MLF1 were expressed in the Escherichia coli BL21 strain using the PGEX-4T2 vector (Invitrogen), and purified using glutathione-sepharose beads (Amersham Biosciences, Piscataway, NJ, USA), as described (Smith and Johnson, 1988) . Cos7 cells overexpressing full-length Flag-MLF1IP were lysed in a buffer containing 1% Nonidet-P-40 (NP40), 2 mM EDTA, 2 mM EGTA, 10 mM sodium fluoride, 1 mM sodium vanadate, 1 mM phenylmethylsulfonylfluroride (PMSF), 1 mg/ml aprotinin, 1 mg/ml antipain and 10 mg/ml leupeptin (Sigma, St Louis, MO, USA). GST-pulldown assays were performed using 0.5 mg of protein lysate incubated with 5 mg of purified GST-control or GST-MLF1 protein immobilized on glutathione-sepharose beads overnight at 41C. Proteins were separated by SDS-PAGE, transferred onto nitrocellulose membrane, probed with anti-Flag M2 mono-clonal antibody (mAb) (Sigma) and detected using the ECL system (Amersham Biosciences).
In vitro transcribed/translated MLF1IP protein labeled with 35 S-methionine (Amersham Biosciences) was obtained using the TNT coupled reticulocyte lysate system (Promega. Madison, WI, USA), diluted in 0.5 ml of modified RIPA buffer without SDS (150 mM NaCl, 1% NP-40, 0.25% deoxycholate, 50 mM Tris-HCl, pH 7.4, 1 mM PMSF, 2 mM EDTA and protease inhibitors) and incubated with equivalent amounts of GST-control, GST-MLF1 or GST-NPM-MLF1. Proteins were separated by SDS-PAGE, the gel was dried and exposed to film to visualize the proteins.
Antibody production and purification
Peptides consisting of 15 amino acids from MLF1IP (amino acids 316-330), or 16 amino acids from MLF1 (amino acids 26-41) were conjugated to KLH and used to immunize rabbits for polyclonal antibody production (Rockland Inc., Gilbertsville, PA, USA). The resulting antisera were tested for specificity and found to recognize both human and mouse proteins.
Anti-MLF1IP was purified using HiTrap protein A column (Amersham Biosciences), and biotinylated with EZ-Link NHS Biotin (Pierce, Rockford, IL, USA).
Confocal microscopy
Cos7 cells grown on coverslips were transfected with cDNA encoding hu-MLF1 or Flag-MLF1IP. Cells were fixed with 3% paraformaldehyde and permeabilized with cold acetone at À201C. Protein localization was detected using rabbit anti-MLF1 or anti-MLF1IP, or mouse anti-Flag M2 mAb, followed by fluorescein (FITC)-conjugated goat anti-rabbit or anti-mouse IgG (Zymed Labs, South San Francisco, CA, USA). DNA was counterstained with propidium iodide. In colocalization experiments, Cos7 cells cotransfected with MLF1 and Flag-MLF1IP were incubated with primary antibodies as above, followed by goat-anti-rabbit-FITC and rat anti-mouse-Texas red (Zymed). Nuclei were visualized using Toto-3 (Vector Labs, Burlingame, CA, USA).
K562 cells were cytocentrifuged, fixed and stained with anti-MLF1 followed by anti-rabbit-FITC, then with anti-MLF1IP-biotinylated and avidin-Texas red. Fluorescence microscopy was performed using a Bio Rad MRC 1024 Olympus confocal microscope system equipped with a krypton-argon laser.
